| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | PL21OR4LXE |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| OTHER | Disialoganglioside GD2 other |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Melanoma | 2 | D008545 | ClinicalTrials |
| Neuroblastoma | 2 | D009447 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Sarcoma | 1 | D012509 | ClinicalTrials |
| Osteosarcoma | 1 | D012516 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109417 |
| FDA SRS | PL21OR4LXE |
CONTENTS